Cell therapy in Parkinson's disease - stop or go?
- PMID: 11331920
- DOI: 10.1038/35072572
Cell therapy in Parkinson's disease - stop or go?
Abstract
The results of the first double-blind placebo-controlled trial using grafts of embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about the future of cell replacement therapies. What are the key issues that need to be resolved and the directions in which this technology is likely to develop?
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
